ArticleBiology2020

Efficacy and Safety of First-Line Everolimus Therapy Alone or in Combination with Octreotide in Gastroenteropancreatic Neuroendocrine Tumors. A Hellenic Cooperative Oncology Group (HeCOG) Study.

Anna Koumarianou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.